WhiteFiber, Inc. Chief Technology Officer Thomas Sanfilippo filed a Form 4 on November 13, 2026, disclosing a disposition of 1,522 ordinary shares on November 10, 2026, in connection with RSU vesting.
Lynne J. Caljouw, Executive Vice President and Chief HR Officer of Sensata Technologies Holding plc, filed a Form 4 on November 13, 2026, disclosing the sale of 7,726 ordinary shares on November 10, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.
Timothy Mark Dyer, Chief Executive Officer and Director of Addex Therapeutics Ltd. (NASDAQ:ADXN), filed a Form 4 on November 13, 2026, disclosing the acquisition of stock options on November 11, 2026.
Director Jason Raleigh Nunn of Addex Therapeutics Ltd. filed a Form 4 on November 13, 2026, disclosing the acquisition of 942,854 stock options on November 11, 2026, with an exercise price of $0.026 per share.
Director Isaac Manke filed a Form 4 with the SEC on November 13, 2026, reporting the acquisition of 942,854 stock options in Addex Therapeutics Ltd. (NASDAQ:ADXN) on November 11, 2026.
Director Mark Steven Lynch filed a Form 4 with the SEC on November 13, 2026, disclosing the sale of 9,533 shares of Appian Corporation Class A Common Stock on November 11, 2026.
Lenaic Nathanael Teyssedou, Principal Accounting Officer of Addex Therapeutics Ltd. (NASDAQ:ADXN), filed a Form 4 on November 13, 2026, disclosing the acquisition of stock options on November 11, 2026.
Addex Therapeutics Ltd. (NASDAQ:ADXN) Chief Medical Officer and Director Roger Mills filed a Form 4 on November 13, 2026, disclosing the acquisition of stock options on November 11, 2026.
Director Raymond George Hill of Addex Therapeutics Ltd. filed a Form 4 on November 13, 2026, disclosing the acquisition of 942,854 stock options on November 11, 2026, with an exercise price of $0.026 per share.
Director Vincent Michael Lawton of Addex Therapeutics Ltd. filed a Form 4 on November 13, 2026, disclosing the acquisition of 942,854 stock options on November 11, 2026, with an exercise price of $0.026 per share and an expiration date of October 11, 2036.